Compare YUM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUM | HLN |
|---|---|---|
| Founded | 1997 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Restaurants | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 41.1B |
| IPO Year | 1997 | N/A |
| Metric | YUM | HLN |
|---|---|---|
| Price | $150.26 | $9.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $168.87 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 9.0M |
| Earning Date | 04-29-2026 | 02-26-2026 |
| Dividend Yield | 1.88% | ★ 1.94% |
| EPS Growth | ★ 6.32 | N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $8,214,000,000.00 | N/A |
| Revenue This Year | $12.11 | $6.55 |
| Revenue Next Year | $5.84 | $4.42 |
| P/E Ratio | $95.48 | ★ $49.05 |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $137.33 | $8.65 |
| 52 Week High | $169.39 | $11.28 |
| Indicator | YUM | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 48.07 |
| Support Level | $148.48 | $9.04 |
| Resistance Level | $155.61 | $9.44 |
| Average True Range (ATR) | 2.93 | 0.12 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 48.93 | 63.27 |
As of the end of 2025, Yum Brands generated over $68 billion in systemwide sales from more than 63,000 restaurants across 155 markets, making it the world's second-largest restaurant firm by dollar sales. Its portfolio includes KFC (33,897 stores), Pizza Hut (19,974), Taco Bell (9,030), and Habit Burger (384), with 72% of locations in international markets. As 97% of its portfolio is franchised, Yum's business model is tilted toward recurring franchise royalties and marketing contributions (64% of revenue), with the balance derived from sales at company-owned locations. The company traces its roots to a 1997 spinoff of PepsiCo's restaurant assets.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.